Looking to publish in Therapeutic Advances in Hematology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginTherapeutic Advances in Hematology is a peer-reviewed open access journal with a strong clinical and pharmacological focus aimed at clinicians and researchers in hematology.
Looking to publish in Therapeutic Advances in Hematology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Therapeutic Advances in Hematology accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
General Reviews
Perspective Reviews
Drug Reviews
Systematic Reviews
Meta-Analyses
Registered Reports – Pre-Data
Registered Reports – Post-Data
Case Reports
Case Series
Brief Reports
Letters To The Editor
Recent Publications
Stanozolol plus avatrombopag for chemoradiotherapy-associated secondary aplastic anemia: A single-center retrospective cohort study
Fen Zeng, Yan He, Yuwei Ling, Yan Lyu, Xiaomei Hu, Richeng Quan
Effectiveness of recombinant factor IX Fc prophylaxis for the treatment of haemophilia B: A systematic review of real-world evidence
Mairead O'Donovan, Francis Fatoye, Tadesse Gebrye, Clara Fatoye, Zalmai Hakimi, Eva Bednar, Daniel Eriksson, Mondher Toumi, Cihan Ay
Real-world acute myeloid leukemia outcomes during a decade of molecular diagnostic expansion and azacitidine plus venetoclax adoption in Thailand: A single-center implementation cohort
Thanawat Rattanathammethee, Noppamas Panyasit, Piangrawee Niprapan, Sirichai Srichairatanakool, Teerachat Punnachet, Nonthakorn Hantrakun, Pokpong Piriyakhuntorn, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Adisak Tantiworawit, Lalita Norasetthada, Ekarat Rattarittamrong
Biomarkers in hematological malignancies: A narrative review of diagnostic, prognostic, and predictive applications
Harshal Chorya, Madhurima Maity, Pratyush Sachdeva, Venkata Balaji Chenna, Tanmayee Mareedu, Prerna Chandra, Falah Fayaz, Salma Younas, Saleh Mohammed, Pooja Gogia Bhasin, Hasibullah Aminpoor
Establishing consensus-based recommendations on first-line ruxolitinib failure and transition for myelofibrosis in Korea: A modified Delphi study
Sung-Eun Lee, Seug Yun Yoon, Junshik Hong, Seung Hyun Nam, Min Kyoung Kim, Ho Jin Shin, Sung Hwa Bae, Jinny Park, Yeung-Chul Mun, Soo-Mee Bang, Chul Won Choi, Chul Won Jung, Jong Ho Won, Ha-Young Kwon, Chanmee Park, Sung-Yong Kim
Frequently asked questions
How long does it take to publish?
Accepted articles can appear online within an average of 30 days after APC processing.
Reformat to Therapeutic Advances in Hematology using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should explain why the manuscript is suitable for publication and, if fast-track publication is requested, explain why.
Reformat to Therapeutic Advances in Hematology using Livewrite PremiumWhat are the publication costs?
Article processing charges apply for hybrid open access journals. Institutional agreements, prepaid accounts, or affiliation-based discounts may help cover APCs.
Reformat to Therapeutic Advances in Hematology using Livewrite Premium